Trials / Conditions / High Cardiovascular Risk

High Cardiovascular Risk

5 registered clinical trials studyying High Cardiovascular Risk — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular NCT07181109	Alnylam Pharmaceuticals	Phase 3
Completed	Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Contro NCT06272487	Alnylam Pharmaceuticals	Phase 2
Terminated	Stress Test on the Prediction of Cardiovascular Events in a High-risk Firefighter Population NCT04423822	Centre Hospitalier Universitaire de Saint Etienne	—
Completed	A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major A NCT02019264	Eisai Inc.	Phase 4
Unknown	Blood Pressure Reduction Induced by CPAP in Sleep Apnea Patients at High Cardiovascular Risk : OPTISAS 2 Study NCT01505959	Fédération Française de Pneumologie	Phase 4